Ann E. Woolfrey

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Claudio G. Brunstein, Jonathan A. Gutman, Daniel J. Weisdorf et al. · Blood · 2010 · 486 citations · Full text

Medicine, Hematology, Obstetrics +17

Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient

Effie W. Petersdorf, Theodore A. Gooley, Claudio Anasetti et al. · Blood · 1998 · 477 citations

Life Sciences, Hematology, Immunology +17

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru et al. · Blood · 2003 · 455 citations · Full text

Medicine, Hematology, Immunology +17

Cord-Blood Transplantation in Patients with Minimal Residual Disease

Filippo Milano, Ted Gooley, Brent L. Wood et al. · New England Journal of Medicine · 2016 · 441 citations · Full text

Medicine, Hematology, Surgery +16

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Craig Kollman, Stephen R. Spellman, Mei-Jie Zhang et al. · Blood · 2015 · 353 citations · Full text

Medicine, Hematology, Surgery +16